Oncolytic Virus Plus Ipilimumab Improves Responses in Advanced Melanoma

The combination of an oncolytic virus with ipilimumab yielded a significantly higher response rate vs ipilimumab alone in patients with advanced melanoma.

Source: CancerNetwork - June 27, 2018 Category: Cancer & Oncology Authors: Dave Levitan Source Type: news